New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 9, 2012
16:45 EDTSNYSanofi Phase II trial of Sanofi JAK2 inhibitor in MF met primary endpoint
Sanofi announced new Phase II data showing that treatment with a novel, investigational, selective JAK2 inhibitor (SAR302503) reduced spleen size and improved constitutional symptoms in patients with intermediate-2 or high-risk primary or secondary myelofibrosis, MF, a hematologic malignancy with unmet medical needs. The data were presented during the 2012 Annual Meeting of the American Society of Hematology in Atlanta, Ga., December 8-11.
News For SNY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
December 1, 2015
11:41 EDTSNYSanofi downgraded to Equal Weight from Overweight at Morgan Stanley
08:38 EDTSNYSanofi launches 24-count tablet pack of Priftin for LTBI
Subscribe for More Information
07:46 EDTSNYFDA and the Parental Drug Association to co-host a conference
Subscribe for More Information
06:15 EDTSNYUnitedHealth unit prefers Sanofi, Regeneron cholesterol shot, Bloomberg says
Subscribe for More Information
November 30, 2015
08:28 EDTSNYSanofi has a conference call hosted by JPMorgan
Subscribe for More Information
08:16 EDTSNYPieris Pharmaceuticals achieves payment milestone in Sanofi collaboration
Subscribe for More Information
November 29, 2015
19:37 EDTSNYSanofi working with Lazard to explore sale of animal health unit, Reuters says
Lazard (LAZ) is working with Sanofi (SNY) to prepare a sale or listing of the company's Merial animal health division, which could value the unit at up to $12.7B, reports Reuters, citing sources. The investment bank is expected to land the lead advisory role for the potential deal, sources told Reuters, which added that the sale would play a "pivotal role" in getting Sanofi "back on track." Reference Link
November 24, 2015
05:23 EDTSNYSanofi, Regeneron announce Praluent ODYSSEY OUTCOMES trial enrollment complete
Subscribe for More Information
November 20, 2015
06:09 EDTSNYSanofi, AstraZeneca to exchange more than 210,000 compounds
Subscribe for More Information
November 18, 2015
08:11 EDTSNYIMS Health forecasts global drug spending to increase 30% by 2020 to $1.4T
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use